The role of 13C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease

Journal of Gastrointestinal and Liver Diseases

Volumn 22, Issue 2, 2013, Pages 149-156

  Fierbinteanu Braticevici, Carmen ^a   Plesca, Doina Anca ^a   Tribus, Laura ^a   Panaitescu, Eugenia ^a   Braticevici, Bogdan ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

13C methacetin breath test (MBT); Cytochrome P450; Liver fibrosis; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CARBON 13; CHOLESTEROL; CYTOCHROME P450; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; IRON; SERUM ALBUMIN; TRIACYLGLYCEROL; URIC ACID; 4 ACETANISIDINE; ACETAMIDE DERIVATIVE; BIOLOGICAL MARKER; CARBON; CARBON DIOXIDE; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXHALATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; BIOPSY; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; FATTY LIVER; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; METHODOLOGY;

ACETAMIDES; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL MARKERS; BIOPSY; BREATH TESTS; CARBON DIOXIDE; CARBON ISOTOPES; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84879175973     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005;17:636-641.
3. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49:1017-1044.
4. Poynard T, Munteanu M, Imbert-Bismut F, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;50:1344-1355.
5. Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gatroenterol 2010; 16: 4784-4791.
6. Grundy SM, Cleeman JI, Merz CN, et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239.
7. Herold C, Heinz R, Niedobitek G, Schneider T, Hahn EG, Schuppan D. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 2001; 21: 260-265.
8. 13C breath tests: visions and realities. J Nutr 2001; 131: 1637S-1642S.
9. Armuzzi A, Candelli M, Zocco MA, et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 2002;16:1977-1996.
10. Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006;40 Suppl 1:S11-16.
11. Vizzutti F, Arena U, Nobili V, et al. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. Ann Hepatol 2009;8:89-94.
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
13. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis. Z Gastroenterol1999;37:1139-1143.
14. 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Scand J Gastroenterol 2006;41:1336-1341.
15. 13C methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis 2000;32:226-232.
16. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 2003; 18: 785-790.
17. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2005; 21:179-185.
18. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis 2008;40:743-748.
19. Razlan H, Marzuki NM, Tai ML, Shamsul AS, Ong TZ, Mahadeva S. Diagnostic value of the Cmethacetin breath test in various stages of chronic liver disease. Gastroenterol Res Pract 2011;2011:235796.
20. 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat 2008;15:716-728.
21. Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci 2006; 111:135-143.
22. 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol 1997;35:609-614.
23. Tarantino G, Conca P, Pasanisi F, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009;21:504-511.
24. Tarantino G, Colicchio P, Conca P, et al. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm 2009;6:6.
25. 13C-octanoate breath test. Am J Gastroenterol 2003; 98: 2335-2336.
26. 13C-caffeine breath test. J Gastroenterol Hepatol 2011; 26:1411-1416.
27. Banasch M, Ellrichmann M, Tannapfel A, Schmidt WE, Goetze O. The non invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in nonalcoholic steatohepatitis. Eur J Med Res 2011;16:258-256.
28. Tarantino G, Conca P, Capone D, Gentile A, Polichetti G, Basile V. Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients. Eur J Clin Pharmacol 2006; 62: 605-612. 29.
29. Tarantino G, Conca P, Riccio A, et al. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? J Transl Med 2008; 6: 72.